Literature DB >> 18627579

Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature.

A V Page1, A J Evans, L Snell, W C Liles.   

Abstract

Mucormycosis (zygomycosis) is an invasive, opportunistic fungal infection caused by organisms of the class Zygomycetes. Immunocompromised individuals, including both solid organ and hematopoietic stem cell transplant recipients, are preferentially affected. Among solid organ transplant (SOT) recipients, the sinuses, with or without involvement of the orbits and cerebrum, are the most common sites of disease, although the pulmonary allograft appears to be targeted following lung transplantation. Here, we describe the unique case of a lung transplant recipient who developed multifocal cutaneous mucormycosis without involvement of the pulmonary allograft, and review the published literature regarding incidence, treatment, and prognosis of primary cutaneous mucormycosis following SOT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18627579     DOI: 10.1111/j.1399-3062.2008.00324.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  9 in total

1.  Successful outcome of mucormycosis in two children on induction therapy for acute lymphoblastic leukemia.

Authors:  Anshul Gupta; Sandeep Jain; Charu Agrawal; Gauri Kapoor
Journal:  Indian J Med Paediatr Oncol       Date:  2013-10

2.  The rise of an opportunistic infection called "Invasive Zygomycosis".

Authors:  Abdelkarim Waness; Ghuzayel Al Dawsari; Hamdan Al Jahdali
Journal:  J Glob Infect Dis       Date:  2009-07

3.  Interleukin-22 mediates early host defense against Rhizomucor pusilluscan pathogens.

Authors:  Wei Bao; Lei Jin; Hai-jing Fu; Yong-nian Shen; Gui-xia Lu; Huan Mei; Xin-zhi Cao; Hong-sheng Wang; Wei-da Liu
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

Review 4.  Mucormycosis in a renal transplant recipient: case report and comprehensive review of literature.

Authors:  Tamim Hamdi; Vanji Karthikeyan; George J Alangaden
Journal:  Int J Nephrol       Date:  2014-02-12

Review 5.  Phylogenetic analysis reveals two genotypes of the emerging fungus Mucor indicus, an opportunistic human pathogen in immunocompromised patients.

Authors:  Saad J Taj-Aldeen; Muna Almaslamani; Bart Theelen; Teun Boekhout
Journal:  Emerg Microbes Infect       Date:  2017-07-12       Impact factor: 7.163

6.  Primary cutaneous Rhizopus folliculitis in an immunocompetent woman.

Authors:  Vanessa E Johnson; Alan S Boyd
Journal:  JAAD Case Rep       Date:  2017-12-18

Review 7.  Cutaneous mucormycosis.

Authors:  Ana Daniela Castrejón-Pérez; Esperanza C Welsh; Ivett Miranda; Jorge Ocampo-Candiani; Oliverio Welsh
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

Review 8.  Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic.

Authors:  Ayushi Sharma; Anjana Goel
Journal:  Folia Microbiol (Praha)       Date:  2022-02-26       Impact factor: 2.629

9.  Disseminated intestinal basidiobolomycosis with mycotic aneurysm mimicking obstructing colon cancer.

Authors:  Arwa Omar Takrouni; Mohammad Heitham Schammut; Mishal Al-Otaibi; Manal Al-Mulla; Antonio Privitera
Journal:  BMJ Case Rep       Date:  2019-01-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.